Simian virus 40 transformation, malignant mesothelioma and brain tumors

References

• Sweet BH, Hilleman MR. The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med.105, 420–427 (1960).
   PubMed Web of Science ®Google Scholar
• Poulin DL, DeCaprio JA. Is there a role for SV40 in human cancer? J. Clin. Oncol.24(26), 4356–4365 (2006).
   PubMed Web of Science ®Google Scholar
• Patel NC, Halvorson SJ, Sroller V et al. Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. Virology386(1), 94–101 (2009).
   PubMed Web of Science ®Google Scholar
• Nakanishi A, Itoh N, Li PP, Handa H, Liddington RC, Kasamatsu H. Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. J. Virol.81(8), 3778–3785 (2007).
   PubMed Web of Science ®Google Scholar
• Kawano MA, Inoue T, Tsukamoto H et al. The VP2/VP3 minor capsid protein of simian virus 40 promotes the in vitro assembly of the major capsid protein VP1 into particles. J. Biol. Chem.281(15), 10164–10173 (2006).
   PubMed Web of Science ®Google Scholar
• Carswell S, Alwine JC. Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J. Virol.60(3), 1055–1061 (1986).
   PubMed Web of Science ®Google Scholar
• Daniels R, Sadowicz D, Hebert DN. A very late viral protein triggers the lytic release of SV40. PLoS Pathog.3(7), e98 (2007).
   Google Scholar
• Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl Cancer Inst.91(2), 119–134 (1999).
   PubMed Web of Science ®Google Scholar
• Stewart AR, Lednicky JA, Butel JS. Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans. J. Neurovirol.4(2), 182–193 (1998).
   PubMed Web of Science ®Google Scholar
• Peden K, Sheng L, Omeir R et al. Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s. Virology370(1), 63–76 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang L, Qi F, Gaudino G et al. Tissue tropism of SV40 transformation of human cells: role of the viral regulatory region and of cellular oncogenes. Genes Cancer1(10), 1008–1020 (2011).
   Google Scholar
• Ewers H, Romer W, Smith AE et al. GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell. Biol.12(1), 11–18; suppl. 11–12 (2010).
   PubMed Web of Science ®Google Scholar
• Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J. Virol.63(10), 4474–4477 (1989).
   PubMed Web of Science ®Google Scholar
• Schelhaas M, Malmstrom J, Pelkmans L et al. Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell131(3), 516–529 (2007).
   PubMed Web of Science ®Google Scholar
• Nakanishi A, Li PP, Qu Q, Jafri QH, Kasamatsu H. Molecular dissection of nuclear entry-competent SV40 during infection. Virus Res.124(1–2), 226–230 (2007).
   PubMed Web of Science ®Google Scholar
• Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat. Rev. Cancer2(12), 957–964 (2002).
   PubMed Web of Science ®Google Scholar
• Wiley SR, Kraus RJ, Zuo F, Murray EE, Loritz K, Mertz JE. SV40 early-to-late switch involves titration of cellular transcriptional repressors. Genes Dev.7(11), 2206–2219 (1993).
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res.68(4), 1022–1029 (2008).
   PubMed Web of Science ®Google Scholar
• Porcu P, Grana X, Li S et al. An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum. Oncogene9(8), 2125–2134 (1994).
   PubMed Web of Science ®Google Scholar
• Chen H, Campisi J, Padmanabhan R. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J. Biol. Chem.271(24), 13959–13967 (1996).
   PubMed Web of Science ®Google Scholar
• Cacciotti P, Libener R, Betta P et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc. Natl Acad. Sci. USA98(21), 12032–12037 (2001).
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene22(1), 81–89 (2003).
   PubMed Web of Science ®Google Scholar
• Okubo E, Lehman JM, Friedrich TD. Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection. J. Virol.77(2), 1257–1267 (2003).
   PubMed Web of Science ®Google Scholar
• Gordon-Shaag A, Ben-Nun-Shaul O, Roitman V, Yosef Y, Oppenheim A. Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. J. Virol.76(12), 5915–5924 (2002).
   PubMed Web of Science ®Google Scholar
• Oppenheim A, Ben-Nun-Shaul O, Mukherjee S, Abd-El-Latif M. SV40 assembly in vivo and in vitro. Comput. Math. Methods Med.9(3–4), 265–276 (2008).
   Web of Science ®Google Scholar
• Manley K, O’Hara BA, Atwood WJ. Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection. Virology372(1), 48–55 (2008).
   PubMed Web of Science ®Google Scholar
• Khalili K, Sariyer IK, Safak M. Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J. Cell. Physiol.215(2), 309–319 (2008).
   PubMed Web of Science ®Google Scholar
• Kriegler M, Perez CF, Hardy C, Botchan M. Transformation mediated by the SV40 T antigens: separation of the overlapping SV40 early genes with a retroviral vector. Cell38(2), 483–491 (1984).
   PubMed Web of Science ®Google Scholar
• Shera KA, Shera CA, McDougall JK. Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J. Virol.75(24), 12339–12346 (2001).
   PubMed Web of Science ®Google Scholar
• Liu J, Kaur G, Zhawar VK et al. Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells. Cancer Res.69(19), 7819–7825 (2009).
   PubMed Web of Science ®Google Scholar
• Jensen F, Koprowski H, Ponten JA. Rapid transformation of human fibroblast cultures by simian virus. Proc. Natl Acad. Sci. USA50, 343–348 (1963).
   PubMed Web of Science ®Google Scholar
• Shein HM. Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia. J. Neuropathol. Exp. Neurol.26(1), 60–76 (1967).
   PubMed Web of Science ®Google Scholar
• Ponten J, Jensen F, Koprowski H. Morphological and virological investigation of human tissue cultures transformed with SV40. J. Cell. Comp. Physiol.61, 145–163 (1963).
   PubMedGoogle Scholar
• Foddis R, De Rienzo A, Broccoli D et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene21(9), 1434–1442 (2002).
   PubMed Web of Science ®Google Scholar
• Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res.68(22), 9488–9496 (2008).
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Carbone M. SV40-mediated oncogenesis. In: Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Pass H, Vogelzan N, Carbone M (Eds). Springer, New York, NY, USA, 34–59 (2005).
   Google Scholar
• De Luca A, Baldi A, Esposito V et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat. Med.3(8), 913–916 (1997).
   PubMed Web of Science ®Google Scholar
• Bocchetta M, Di Resta I, Powers A et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl Acad. Sci. USA97(18), 10214–10219 (2000).
   PubMed Web of Science ®Google Scholar
• Sroller V, Vilchez RA, Stewart AR, Wong C, Butel JS. Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters. J. Virol.82(2), 871–879 (2008).
   PubMed Web of Science ®Google Scholar
• Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am. J. Pathol.142(5), 1524–1533 (1993).
   PubMed Web of Science ®Google Scholar
• Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell37(2), 367–379 (1984).
   PubMed Web of Science ®Google Scholar
• Palmiter RD, Chen HY, Messing A, Brinster RL. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature316(6027), 457–460 (1985).
   PubMed Web of Science ®Google Scholar
• Lee YC, Asa SL, Drucker DJ. Glucagon gene 5’-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J. Biol. Chem.267(15), 10705–10708 (1992).
   PubMed Web of Science ®Google Scholar
• Saenz Robles MT, Pipas JM. T antigen transgenic mouse models. Semin. Cancer Biol.19(4), 229–235 (2009).
   PubMed Web of Science ®Google Scholar
• Hanahan D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature315(6015), 115–122 (1985).
   PubMed Web of Science ®Google Scholar
• Wikenheiser KA, Clark JC, Linnoila RI, Stahlman MT, Whitsett JA. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res.52(19), 5342–5352 (1992).
   PubMed Web of Science ®Google Scholar
• Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl Acad. Sci. USA91(23), 11236–11240 (1994).
   PubMed Web of Science ®Google Scholar
• Greenberg NM, DeMayo F, Finegold MJ et al. Prostate cancer in a transgenic mouse. Proc. Natl Acad. Sci. USA92(8), 3439–3443 (1995).
   PubMed Web of Science ®Google Scholar
• Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED. The TRAMP mouse as a model for prostate cancer. Curr. Protoc. Immunol. Chapter 20, Unit 20.5 (2001).
   PubMedGoogle Scholar
• Santarelli R, Tzeng YJ, Zimmermann C, Guhl E, Graessmann A. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Oncogene12(3), 495–505 (1996).
   PubMed Web of Science ®Google Scholar
• Perez-Stable C, Altman NH, Brown J, Harbison M, Cray C, Roos BA. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Lab. Invest.74(2), 363–373 (1996).
   PubMed Web of Science ®Google Scholar
• Garabedian EM, Roberts LJ, McNevin MS, Gordon JI. Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J. Biol. Chem.272(38), 23729–23740 (1997).
   PubMed Web of Science ®Google Scholar
• Garabedian EM, Humphrey PA, Gordon JI. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc. Natl Acad. Sci. USA95(26), 15382–15387 (1998).
   PubMed Web of Science ®Google Scholar
• Asamoto M, Hokaiwado N, Cho YM et al. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res.61(12), 4693–4700 (2001).
   PubMed Web of Science ®Google Scholar
• Masumori N, Thomas TZ, Chaurand P et al. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res.61(5), 2239–2249 (2001).
   PubMed Web of Science ®Google Scholar
• Gabril MY, Onita T, Ji PG et al. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gene Ther.9(23), 1589–1599 (2002).
   PubMed Web of Science ®Google Scholar
• Hicks SM, Vassallo JD, Dieter MZ et al. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis. Toxicology187(2–3), 217–228 (2003).
   PubMed Web of Science ®Google Scholar
• Garson K, Macdonald E, Dube M, Bao R, Hamilton TC, Vanderhyden BC. Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J. Soc. Gynecol. Investig.10(4), 244–250 (2003).
   PubMedGoogle Scholar
• Lou DQ, Molina T, Bennoun M et al. Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences. Cancer Lett.229(1), 107–114 (2005).
   PubMed Web of Science ®Google Scholar
• Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am. J. Pathol.157(3), 805–813 (2000).
   PubMed Web of Science ®Google Scholar
• Robinson C, van Bruggen I, Segal A et al. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res.66(22), 10786–10794 (2006).
   PubMed Web of Science ®Google Scholar
• Köbbert C, Mollmann C, Schafers M et al. Transgenic model of cardiac rhabdomyosarcoma formation. J. Thorac. Cardiovasc. Surg.136(5), 1178–1186 (2008).
   PubMed Web of Science ®Google Scholar
• ter Brugge PJ, Ta VB, de Bruijn MJ et al. A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen. Blood114(1), 119–127 (2009).
   PubMed Web of Science ®Google Scholar
• Stahl S, Sacher T, Bechtold A et al. Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma. Immunol. Lett.123(1), 31–37 (2009).
   PubMed Web of Science ®Google Scholar
• Iwakura H, Ariyasu H, Li Y et al. A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance. Am. J. Physiol. Endocrinol. Metab.297(3), E802–E811 (2009).
   Google Scholar
• Pass HI, Vogelzang N, Hahn SM, Carbone M. Benign and malignant mesothelioma. In: Cancer, Principles & Practice of Oncology. De Vita VT, Hellmann S, Rosemberg SA (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA, 1687–1715 (2005).
   Google Scholar
• Carbone M, Ly BH, Dodson RF et al. Malignant mesothelioma: Facts, myths and hypotheses. J. Cell. Physiol. DOI: 10.1002/jcp.22724 (2011) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Ramos-Nino ME, Testa JR, Altomare DA et al. Cellular and molecular parameters of mesothelioma. J. Cell. Biochem.98(4), 723–734 (2006).
   PubMed Web of Science ®Google Scholar
• Cacciotti P, Barbone D, Porta C et al. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res.65(12), 5256–5262 (2005).
   PubMed Web of Science ®Google Scholar
• Gee GV, Stanifer ML, Christensen BC et al. SV40 associated miRNAs are not detectable in mesotheliomas. Br. J. Cancer103(6), 885–888 (2010).
   PubMed Web of Science ®Google Scholar
• Cacciotti P, Strizzi L, Vianale G et al. The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am. J. Respir. Cell Mol. Biol.26(2), 189–193 (2002).
   PubMed Web of Science ®Google Scholar
• Strizzi L, Catalano A, Vianale G et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol.193(4), 468–475 (2001).
   PubMed Web of Science ®Google Scholar
• Kroczynska B, Cutrone R, Bocchetta M et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc. Natl Acad. Sci. USA103(38), 14128–14133 (2006).
   PubMed Web of Science ®Google Scholar
• Pietruska JR, Kane AB. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res.67(8), 3637–3645 (2007).
   PubMed Web of Science ®Google Scholar
• Yang H, Bocchetta M, Kroczynska B et al. TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc. Natl Acad. Sci. USA103(27), 10397–10402 (2006).
   PubMed Web of Science ®Google Scholar
• Sartore-Bianchi A, Gasparri F, Galvani A et al. Bortezomib inhibits nuclear factor-κB dependent survival and has potent in vivo activity in mesothelioma. Clin. Cancer Res.13(19), 5942–5951 (2007).
   PubMed Web of Science ®Google Scholar
• Yang H, Rivera Z, Jube S et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc. Natl Acad. Sci. USA107(28), 12611–12616 (2010).
   PubMed Web of Science ®Google Scholar
• Henzi T, Blum WV, Pfefferli M, Kawecki TJ, Salicio V, Schwaller B. SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis. Am. J. Pathol.174(6), 2324–2336 (2009).
   PubMed Web of Science ®Google Scholar
• Comar M, Rizzardi C, de Zotti R et al. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res.67(18), 8456–8459 (2007).
   PubMed Web of Science ®Google Scholar
• Zekri AR, Bahnassy AA, Mohamed WS et al. Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma. Pathol. Int.57(8), 493–501 (2007).
   PubMed Web of Science ®Google Scholar
• Degiovanni D, Pesce B, Pondrano N. Asbestos in Italy. Int. J. Occup. Environ. Health10(2), 193–197 (2004).
   PubMed Web of Science ®Google Scholar
• Pancaldi C, Balatti V, Guaschino R et al. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J. Infect.58(1), 53–60 (2009).
   PubMed Web of Science ®Google Scholar
• Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology318(1), 1–9 (2004).
   PubMed Web of Science ®Google Scholar
• Cutrone R, Lednicky J, Dunn G et al. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res.65(22), 10273–10279 (2005).
   PubMed Web of Science ®Google Scholar
• Morris JA, Johnson KM, Aulisio CG, Chanock RM, Knight V. Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route. Proc. Soc. Exp. Biol. Med.108, 56–59 (1961).
   PubMed Web of Science ®Google Scholar
• Horvath BL, Fornosi F. Excretion of SV-40 virus after oral administration of contaminated polio vaccine. Acta Microbiol. Acad. Sci. Hung.11, 271–275 (1964).
   PubMedGoogle Scholar
• Li RM, Branton MH, Tanawattanacharoen S, Falk RA, Jennette JC, Kopp JB. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J. Am. Soc. Nephrol.13(9), 2320–2330 (2002).
   PubMed Web of Science ®Google Scholar
• Patel NC, Vilchez RA, Killen DE et al. Detection of polyomavirus SV40 in tonsils from immunocompetent children. J. Clin. Virol.43(1), 66–72 (2008).
   PubMed Web of Science ®Google Scholar
• Vanchiere JA, Nicome RK, Greer JM, Demmler GJ, Butel JS. Frequent detection of polyomaviruses in stool samples from hospitalized children. J. Infect. Dis.192(4), 658–664 (2005).
   PubMed Web of Science ®Google Scholar
• Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS. Polyomavirus shedding in the stool of healthy adults. J. Clin. Microbiol.47(8), 2388–2391 (2009).
   PubMed Web of Science ®Google Scholar
• Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene21(8), 1141–1149 (2002).
   PubMed Web of Science ®Google Scholar
• Carbone M, Pass HI, Rizzo P et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene9(6), 1781–1790 (1994).
   PubMed Web of Science ®Google Scholar
• Testa JR, Carbone M, Hirvonen A et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res.58(20), 4505–4509 (1998).
   PubMed Web of Science ®Google Scholar
• Ramael M, Nagels J, Heylen H et al. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. Eur. Respir. J.14(6), 1381–1386 (1999).
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Wiethege T, Wistuba II et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J. Cell. Biochem.76(2), 181–188 (1999).
   PubMed Web of Science ®Google Scholar
• De Rienzo A, Tor M, Sterman DH, Aksoy F, Albelda SM, Testa JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J. Cell. Biochem.84(3), 455–459 (2002).
   PubMed Web of Science ®Google Scholar
• Priftakis P, Bogdanovic G, Hjerpe A, Dalianis T. Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas. Anticancer Res.22(3), 1357–1360 (2002).
   PubMed Web of Science ®Google Scholar
• Cristaudo A, Foddis R, Vivaldi A et al. SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. Cancer Res.65(8), 3049–3052 (2005).
   PubMed Web of Science ®Google Scholar
• Leithner A, Weinhaeusel A, Windhager R et al. Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas. Cancer Biol. Ther.1(4), 375–379 (2002).
   PubMed Web of Science ®Google Scholar
• Hubner R, Van Marck E. Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Biol. Ther13(2), 121–129 (2002).
   Google Scholar
• Mayall F, Barratt K, Shanks J. The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J. Clin. Pathol.56(10), 728–730 (2003).
   PubMed Web of Science ®Google Scholar
• Brousset P, Sabatier J, Galateau-Salle F. SV40 infection in human cancers. Ann. Oncol.16(7), 1212–1213 (2005).
   PubMed Web of Science ®Google Scholar
• Weiss AF, Portmann R, Fischer H, Simon J, Zang KD. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc. Natl Acad. Sci. USA72(2), 609–613 (1975).
   PubMed Web of Science ®Google Scholar
• Weiss AF, Zang KD, Birkmayer GD, Miller F. SV 40 related papova-viruses in human meningiomas. Acta Neuropathol.34(2), 171–174 (1976).
   PubMed Web of Science ®Google Scholar
• Vilchez RA, Butel JS. SV40 in human brain cancers and non-Hodgkin’s lymphoma. Oncogene22(33), 5164–5172 (2003).
   PubMed Web of Science ®Google Scholar
• Wang J, Garcea RL. Simian virus 40 DNA sequences in human brain and bone tumours. Dev. Biol. Stand.94, 13–21 (1998).
   PubMedGoogle Scholar
• Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P, Ohgaki H. Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol.9(1), 33–42 (1999).
   PubMed Web of Science ®Google Scholar
• Rollison DE, Utaipat U, Ryschkewitsch C et al. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int. J. Cancer113(5), 769–774 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA, Pomeroy SL. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro. Oncol.4(3), 165–170 (2002).
   PubMed Web of Science ®Google Scholar
• Montesinos-Rongen M, Besleaga R, Heinsohn S et al. Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients. Virchows Arch.444(5), 436–438 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatier J, Uro-Coste E, Benouaich A et al. Immunodetection of SV40 large T antigen in human central nervous system tumours. J. Clin. Pathol.58(4), 429–431 (2005).
   PubMed Web of Science ®Google Scholar
• Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med.326(15), 988–993 (1992).
   PubMed Web of Science ®Google Scholar
• Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene20(33), 4441–4449 (2001).
   PubMed Web of Science ®Google Scholar
• Meneses A, Lopez-Terrada D, Zanwar P et al. Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica90(12), 1635–1642 (2005).
   PubMed Web of Science ®Google Scholar
• Zekri AR, Mohamed W, Bahnassy A et al. Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies. Leuk. Lymphoma48(9), 1828–1834 (2007).
   PubMed Web of Science ®Google Scholar
• Amara K, Trimeche M, Ziadi S et al. Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes. Int. J. Cancer121(12), 2693–2702 (2007).
   PubMed Web of Science ®Google Scholar
• Heinsohn S, Scholz R, Kabisch H. SV40 and p53 as team players in childhood lymphoproliferative disorders. Int. J. Oncol.38(5), 1307–1317 (2011).
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Nakayama T, Murakami H et al. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br. J. Cancer82(10), 1677–1681 (2000).
   PubMed Web of Science ®Google Scholar
• Heinsohn S, Szendroi M, Bielack S, Stadt UZ, Kabisch H. Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study. Oncol. Rep.21(2), 289–297 (2009).
   PubMed Web of Science ®Google Scholar
• Hachana M, Trimeche M, Ziadi S, Amara K, Korbi S. Evidence for a role of the Simian virus 40 in human breast carcinomas. Breast Cancer Res. Treat.113(1), 43–58 (2009).
   PubMed Web of Science ®Google Scholar
• Campello C, Comar M, Zanotta N, Minicozzi A, Rodella L, Poli A. Detection of SV40 in colon cancer: a molecular case-control study from northeast Italy. J. Med. Virol.82(7), 1197–1200 (2010).
   PubMed Web of Science ®Google Scholar
• Sangar D, Pipkin PA, Wood DJ, Minor PD. Examination of poliovirus vaccine preparations for SV40 sequences. Biologicals27(1), 1–10 (1999).
   PubMed Web of Science ®Google Scholar
• Pershouse MA, Heivly S, Girtsman T. The role of SV40 in malignant mesothelioma and other human malignancies. Inhal. Toxicol.18(12), 995–1000 (2006).
   PubMed Web of Science ®Google Scholar
• Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet364(9440), 1157–1166 (2004).
   PubMed Web of Science ®Google Scholar
• Gordon GJ, Chen CJ, Jaklitsch MT, Richards WG, Sugarbaker DJ, Bueno R. Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. Oncol. Rep.9(3), 631–634 (2002).
   PubMed Web of Science ®Google Scholar
• Jin M, Sawa H, Suzuki T et al. Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. J. Med. Virol.74(4), 668–676 (2004).
   PubMed Web of Science ®Google Scholar
• Aoe K, Hiraki A, Murakami T et al. Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Sci.97(4), 292–295 (2006).
   PubMed Web of Science ®Google Scholar
• Hmeljak J, Kern I, Cor A. No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia. Tumori96(5), 667–673 (2010).
   PubMed Web of Science ®Google Scholar
• Stratton K, Almario DA; IOM. Immunization safety review: SV40 contamination of polio vaccines and cancer. In: Institute of Medicine (IOM). The National Academy of Sciences, Washington, DC, USA (2002).
   Google Scholar
• Liu J, Li H, Nomura K, Dofuku R, Kitagawa T. Cytogenetic analysis of hepatic cell lines derived from SV40-T antigen gene-harboring transgenic mice. Cancer Genet. Cytogenet.55(2), 207–216 (1991).
   PubMedGoogle Scholar
• Carbone M, Rdzanek MA, Rudzinski JJ et al. SV40 detection in human tumor specimens. Cancer Res.65(21), 10120–10121 (2005).
   PubMed Web of Science ®Google Scholar
• Carbone M, Rizzo P, Procopio A et al. SV40-like sequences in human bone tumors. Oncogene13(3), 527–535 (1996).
   PubMed Web of Science ®Google Scholar
• Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog.5(3), e1000363 (2009).
   PubMed Web of Science ®Google Scholar
• Ferber D. Public health. Creeping consensus on SV40 and polio vaccine. Science298(5594), 725–727 (2002).
   PubMed Web of Science ®Google Scholar
• Cantalupo PG, Saenz-Robles MT, Rathi AV et al. Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology386(1), 183–191 (2009).
   PubMed Web of Science ®Google Scholar